Skip to main content
. 2009 Apr 7;94(7):2360–2366. doi: 10.1210/jc.2008-2606

Table 3.

Clinical and hormonal characteristics of Tanner 3-5 HA P-sensitive and P-insensitive subjects

HA P-sensitive (n = 15) HA P-insensitive (n = 9)
Age (yr) 16.0 ± 1.5 (0.4, 16.1) 16.2 ± 2.1 (0.7, 16.0)
Years postmenarche 3.7 ± 1.7 (0.4, 3.0) 3.6 ± 2.0 (0.7, 0.9)
BMI (kg/m2) 34.1 ± 8.1 (2.1, 31.8) 33.4 ± 7.0 (2.3, 33.6)
BMI-for-age percentile 93 ± 10.3 (3, 96) 89 ± 24 (8, 98)
Ethnicity (no. of subjects)
 Hispanic 8 1
 Non-Hispanic 7 8
Baseline
 Total T (ng/dl) 55.8 ± 16.2 (4.2, 59.0) 43.7 ± 16.5 (5.5, 49.0)
 SHBG (nmol/liter) 16.6 ± 8.5 (2.2, 15.1) 16.9 ± 12.0 (4.0, 12.3)
 Free T (pg/ml) 14.3 ± 4.7 (1.2, 12.6) 12.0 ± 6.1 (2.0, 14.0)
 DHEAS (μg/dl) 137 ± 72 (21, 126) 153 ± 75 (25, 162)
 Androstenedione (ng/ml) 2.3 ± 1.1 (0.3, 2.0) 1.9 ± 0.6 (0.2, 1.7)
 E1 (pg/ml) 57.7 ± 20.2 (5.2, 61.0) 51.7 ± 22.1 (7.4, 38.6)
 E2 (pg/ml) 66.9 ± 13.6 (3.5, 65.9) 57.3 ± 23.6 (7.9, 54.2)
 P (ng/ml) 0.6 ± 0.1 (0.0, 0.6) 0.6 ± 0.2 (0.1, 0.6)
 LH (IU/liter) 7.7 ± 3.7 (1.0, 7.5) 8.4 ± 5.5 (1.8, 6.4)
 FSH (IU/liter) 3.8 ± 0.5 (0.1, 3.8) 4.0 ± 1.1 (0.4, 3.5)
 Fasting insulin (μIU/ml) 22.2 ± 13.9 (3.6, 18.1) 39.6 ± 30.6 (10.2, 29.4)a
Day 7
 Total T (ng/dl) 50.8 ± 14.4 (3.7, 50.1) 46.6 ± 19.0 (6.3, 44.0)
 SHBG (nmol/liter) 19.4 ± 10.1 (2.6, 17.9) 18.9 ± 13.2 (4.4, 14.7)
 Free T (pg/ml) 12.2 ± 3.9 (1.0, 11.7) 12.1 ± 6.4 (2.1, 11.7)
 Androstenedione (ng/ml) 1.9 ± 0.8 (0.2, 1.7) 1.8 ± 0.6 (0.2, 1.7)
 E1 (pg/ml) 142 ± 52 (13, 146) 161 ± 64 (22, 149)
 E2 (pg/ml) 128 ± 49 (13, 114) 114 ± 44 (15, 123)
 P (ng/ml) 6.9 ± 2.0 (0.5, 7.3) 8.9 ± 3.9 (1.3, 9.7)
 LH (IU/liter) 6.4 ± 3.1 (0.8, 6.4) 7.0 ± 3.3 (1.1, 5.1)
 FSH (IU/liter) 3.1 ± 0.5 (0.1, 3.0) 3.4 ± 1.1 (0.4, 2.9)

Data are presented as mean ± sd (sem, median). Insulin levels on d 7 were not reported because subjects were not fasting secondary to snack given with 2300 h dose of P. 

a

P = 0.02.